Internal Medicine, Hematology & Oncology · Midland, MI
NPI
1144244500
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
4201 Campus Ridge Dr
Midland, MI, 48640
Phone (989) 839-6188
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,154 services
Medicare patients, 2024
264
Average age 73
Drug cost, 2024
$3.8M
2,030 prescriptions
Company payments, 2025
$56.48
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharon A Levandowski was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 350 times for 152 patients. In total Sharon A Levandowski billed 1,154 services in 17 codes, and Medicare paid $71K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 350 | 152 | $13.41 | $4,692 |
| 99214 Office E&M - Established | Office | 242 | 137 | $78.47 | $19K |
| 99215 Office E&M - Established | Office | 127 | 79 | $117.52 | $15K |
| 99215 Office E&M - Established | Facility | 95 | 69 | $102.62 | $9,749 |
| 99214 Office E&M - Established | Facility | 89 | 65 | $69.95 | $6,226 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 87 | 57 | $13.13 | $1,142 |
| 99205 Office E&M - New | Office | 29 | 29 | $148.98 | $4,320 |
| 99204 Office E&M - New | Facility | 19 | 19 | $77.38 | $1,470 |
| 99232 Hospital E&M - Subsequent | Facility | 18 | 11 | $64.46 | $1,160 |
| 99204 Office E&M - New | Office | 17 | 17 | $97.04 | $1,650 |
| 99205 Office E&M - New | Facility | 16 | 16 | $124.41 | $1,991 |
| 99213 Office E&M - Established | Office | 11 | 11 | $54.01 | $594 |
By year: 2022 $26K for 436 services; 2023 $23K for 372 services; 2024 $71K for 1,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sharon A Levandowski prescribed most often to Medicare patients was Anastrozole, with 262 prescriptions and refills. In total Sharon A Levandowski wrote 2,030 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 262 | 699 | 108 | $13K |
| Acyclovir Generic | 131 | 157 | 24 | $1,820 |
| Ondansetron Odt Ondansetron | 106 | 106 | 67 | $1,960 |
| Eliquis Apixaban | 73 | 97 | 19 | $56K |
| Dexamethasone Generic | 66 | 71 | 22 | $903 |
| Prochlorperazine Maleate Generic | 65 | 65 | 46 | $1,334 |
| Letrozole Generic | 62 | 146 | 23 | $2,694 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 55 | 55 | 24 | $1,273 |
| Hydroxyurea Generic | 39 | 80 | 14 | $1,762 |
| Tamoxifen Citrate Generic | 38 | 100 | 28 | $1,602 |
| Lenalidomide Generic | 36 | 36 | Under 11 | $576K |
| Ibrance Palbociclib | 35 | 39 | Under 11 | $624K |
| Prednisone Generic | 34 | 40 | 20 | $136 |
| Venclexta Venetoclax | 34 | 34 | Under 11 | $234K |
| Potassium Chloride Generic | 33 | 49 | 16 | $436 |
Brand drugs: - claims; generic drugs: 1,703 claims; opioid claims: 102.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharon A Levandowski $56.48 ($56.48 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $56.48.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $56.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.